STAT3 and hyper-IgE syndrome: The clinical relevance of the Th17-Th2 counter-regulatory mechanism is also highlighted by the monogenic Hyper-IgE syndrome, whereby defective STAT3 leads to the cardinal features of AD, including eczematous lesions on skin, S. aureus infections, and type 2 immune responses with high IgE [72].